Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

JAK inhibitors are effective for long-term management of alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

JAK inhibitors offer new hope for treating severe alopecia areata.

Many patients on new leukemia drugs had mild to moderate skin reactions.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Biotin supplements did not significantly reduce hair loss in rats on valproic acid.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Topical Ruxolitinib may safely treat severe hair loss.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

AH-001 could be a safer and more effective treatment for hair loss.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Vitamin D3 and its receptor help protect skin from UVB-related cancer.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.